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Abstract

Post-TBI Hippocampal Neurogenesis in Different TBI Models
By
Kaushal S. Patel
A thesis submitted in partial fulfillment of the requirements for the degree of Master
of Science at Virginia Commonwealth University
Virginia Commonwealth University, 2016
Advisor: Dong Sun, MD, PhD, Department of Neurosurgery

Traumatic brain injury (TBI) leads to short-term and long-term consequences that
can cause many different life-long disorders. Studies of TBI have generally focused on
the acute stage; however, it is now becoming important to investigate chronic responses
following TBI as clinical reports of dementia and cognitive impairments have been linked
to a history of TBI. Recent data have established that cognitive function is associated
with hippocampal neurogenesis. Chronic injury induced changes in the brain may affect
this endogenous process. Chronic responses following TBI include cell death pathways
and inflammatory responses that are persistent in the brain for months to years after
injury. In this study we investigate the chronic consequences of TBI on adult
neurogenesis and the possible involvement of chronic-inflammation in regulating adult
neurogenesis. We used two popular TBI animal models, Control Cortical Impact (CCI)
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and Lateral Fluid Percussion Injury (LFPI) models, to examine focal and diffuse injury
responses respectively. Adult rats received CCI, LFPI, or sham injury and were sacrificed
at either 15 days or 3 months after injury to examine either subacute or chronic TBIinduced responses respectively. We found no change in levels of proliferation activity at
both time points in both TBI models compared to sham animals. Using Doublecortin
immunolabeling we found an enhanced generation of new neurons at 15 days after injury
and by 3 months this activity was significantly reduced in both TBI models compared to
sham animals. We also found persistent inflammation in the injured brains at both time
points. Morphological assessment showed that LFPI model of TBI causes shrinkage of
the ipsilateral hippocampus. Our results show that moderate TBI induced hippocampal
neurogenesis in both models at the early time post-injury. However, at chronic stage,
reduced hippocampal neurogenesis is observed in both models and this is accompanied
by chronic inflammation. These results suggest that persistent inflammatory responses
maybe detrimental to normal neurogenic activity, leading to cognitive impairment and
neurodegeneration in long-term TBI survivors.

xiii

Chapter 1 - Introduction and Background
Traumatic Brain Injury (TBI) is a major cause of death and life-long disability
worldwide. It is defined as a physical insult to the brain, which disrupts normal brain
functions and can be caused by a bump, blow, or jolt to the head (Marr and Coronado,
2004). Various accidents such as car crashes, sports injuries, war related injuries, etc.,
could lead to TBI. Damaging factors of TBI can have acute and chronic consequences
leading to many neurological disorders such as memory loss, behavioral dysfunction,
epilepsy, dementia, and sleep disorders.

Various animal models have been developed to study TBI. These models work by
replicating specific aspects of a TBI to study acute and/or chronic injury mechanisms.
Using various TBI animal models, many studies have shown an injury-induced upregulation in adult neurogenesis (Sun et al., 2005; Sun, 2016). These study have found an
increase in proliferation of neural stem cells (NSC) and neural progenitor cells (NPC) in
response to injury in the subventricular zone (SVZ) of the lateral ventricles and the
dentate gyrus (DG) of the hippocampus (Dash et al., 2001; Rice et al., 2003). This
neurogenic response after injury indicates that the brain has a limited ability to initiate
mechanisms for repair and regeneration. Our lab has shown that injury-induced changes
in hippocampal neurogenesis are related to innate cognitive recovery (Sun et al., 2015).
Spontaneous cognitive recovery seen in many TBI patients may be a result of this
endogenous neurogenic response.
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Most TBI studies focus on acute and subacute changes after injury. However,
there are growing number of clinical reports of long-term TBI patients that have
developed neurodegenerative diseases and cognitive dysfunction (Mayeux et al., 1995;
Castriotta et al., 2007). We hypothesize that neurodegeneration and cognitive dysfunction
maybe a consequence of long-term injury-induced changes in adult neurogenesis. We
suspect persistent secondary injury mechanisms of chronic-TBI such as
neuroinflammation may be responsible for these neurogenic changes.

Studies have shown that chronic-neuroinflammation can have a detrimental
impact on adult neurogenesis (Fuster-Matanzo et al., 2013). In this study we used two
popular TBI animal models, controlled cortical impact (CCI) injury and lateral fluid
percussion injury (LFPI) models, to explore changes in adult neurogenesis in the chronicTBI stage and the association of these changes to neuroinflammation.

Epidemiology
TBI affects millions of people worldwide every year. According to the Centers
for Disease Control and Prevention (CDC), in the United States alone, 16% of all injury
related emergency department (ED) visits are diagnosed as TBI. About 1.7 million people
each year are affected by TBI in the United States. Many people that survive the injury
develop life long disabilities. In the beginning of 2005 about 3.17 million people in the
United States were living with long-term disability resulting from TBI (Zaloshnja et al.,
2008). In 2010 the economic burden of TBI was about $76.5 billion, not including TBIs
managed in non-hospital locations and at federal institutions (Finkelstein et al., 2006).
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Highest rate of TBI related hospitalizations and deaths occur in adults over 75
years of age and 775,000 elderly adults develop life-long disabilities (Zaloshnja et al.,
2008). With pre-existing medical conditions and slower rates of functional
improvements, elderly adults are more likely to have longer hospital stays and higher risk
of mortality (Mosenthal et al., 2004; Thompson et al., 2006).

The leading cause of TBI related ED visits is due to falls, and leading causes of
TBI related deaths is motor vehicle accidents and suicides (Coronado et al., 2012). In
2010, TBI caused about 50,000 total deaths, not accounting for people that did not
receive medical care or people diagnosed at federal facilities (Faul et al., 2010).
According to the Department of Defense, about 5.6 million United States military
members from 2000 – 2011 were diagnosed with TBI (CDC, 2015). Combat situations
that result in mild TBI may lead to increased risk of post-traumatic stress disorder
(Bryant et al., 2010) which can further increase risk for various post-concussive
symptoms (Brenner et al., 2010).

Since 1980, hospitalization rate for mild TBI has significantly decreased due to
improved safety and accident prevention programs whereas hospitalization rate for severe
TBI has increased mainly due to improved availability and quality of medical treatments
leading to greater survivability (Summers et al., 2009). This increase in survival rate
leads to a greater number of people suffering from long-term disabilities after TBI. It is
important to address these concerns of chronic-TBI by studying the mechanisms
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regulating the spread of injury damages and developing treatments to reduce and/or
reverse these damages.

Biomechanics and mechanisms of TBI
The cause of a TBI is a physical force that acts on the head resulting in structural
damages and eventually causes damages to the brain at the cellular and biochemical
levels. These cellular and biochemical changes then lead to cognitive and behavioral
dysfunction. The underlying damages of a TBI can vary depending on the type and way
injury is induced. The mechanical insults to the head can be characterized in three general
categories: impact, impulse, and static. Impact occurs to the head with high magnitude
and short duration of 50 ms or less causing deformation of the skull and brain tissue
damage (Davis, 2000). Impulse occurs when there is a sudden change of head motion due
to acceleration or deceleration of the body and does not involve deformation of the skull
(Davis, 2000). Static involves long duration, greater than 200 ms of compressive force to
the head causing skull deformation (Davis, 2000).

The injuries caused to the brain tissue can be focal or diffuse. Focal injury occurs
when the injury is focused on a particular area of the brain caused by a direct blow to the
head and involves contusion, brain laceration, and hemorrhage (Gennarelli, 1993).
Diffuse injury usually involves widespread microscopic damages caused by sudden head
movement and involves concussion and diffuse axonal injury (Gennarelli, 1993).
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The magnitude and duration of the mechanical force determines the extent of
brain injury along with accompanying damages such as brain hemorrhage and swelling
(Xiong et al., 2013). The resulting immediate damages are referred to as the primary
injury. Besides the skull fracture and brain tissue damage, primary injury can also cause
the initiation of secondary injury mechanisms (Xiong et al., 2013). Secondary injury
involves non-mechanical damages such as increased intracranial pressure, reduced
cerebral blood flow, blood brain barrier damage, bleeding, edema, diffuse axonal injury,
cell death, and neurovascular damage (Xiong et al., 2015). A complex interplay of
cellular and biochemical mechanisms such as excitotoxicity, mitochondrial damage,
changes in gene expression, inflammatory responses, and oxidative stress are involved in
the spread of secondary injury (Xiong et al., 2013). However, the onset of secondary
injury mechanisms can happen seconds to months after injury, providing a therapeutic
window of opportunity for treatment against the spread of damages after TBI.

Pathology of TBI
Physical damages to the brain can lead to long-term cognitive impairments and
significantly increase chances of developing neurological diseases (Koponen et al.,
2002). Diffuse axonal injury serves as a clinical hallmark of human TBI and studies show
that damage to white matter tracks correlate with declined cognitive function (Kraus et
al., 2007). For example, using diffuse tensor imaging and neurophysiological testing, one
study showed that TBI patients with greater white matter pathology had greater cognitive
deficits (Kraus et al., 2007). Memory and attention are commonly impaired at all levels
of TBI injury (Lovell and Franzen, 1994).
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Cognitive deficits can have a devastating impact on social behavior and lifestyle,
which also affects the lives of caregivers such as family and friends. Furthermore,
behavioral changes in TBI patients may implicate the development of psychiatric
disorders (Castriotta et al., 2007). Studies have reported that as many as half of TBI
outpatients may be suffering from psychiatric disorders, and patients with pre-existing
conditions have a higher likelihood of developing other disorders such as depression,
anxiety, sleep disorders, and substance abuse (Koponen et al., 2002; Hibbard et al.,
1998). Disruption of the normal sleep cycle, causing various sleep disorders such as
obstructive sleep apnea, posttraumatic hypersomnia, and narcolepsy, has also been linked
to post-TBI consequences in about half of TBI outpatients (Castriotta et al., 2007). TBI
also increases chance of death from other diseases. In some studies, TBI patients were
more likely to die from seizures, septicemia, pneumonia, digestive disorders, and
circulatory disorders compared to patients without a TBI history (Harrison-Felix et al.,
2006; Harrison-Felix et al., 2009; Shavelle et al., 2001).

Surviving TBI patients often suffer from long-term neurological disorders such as
epilepsy and dementia. There is a rising concern about the relationship between TBI and
dementia. For example, TBI patients who have the ApoR E4 allele, which has been
implicated in Alzheimer’s disease, are 10 times more likely to develop Alzheimer’s
disease than healthy people (Mayeux et al., 1995). Studies have reported that TBI induces
up-regulation or activation of certain biochemical mechanisms that have also been found
to play a role in these degenerative diseases (Uryu et al., 2007). Although the detailed
mechanisms of these processes are unclear, secondary injury mechanisms such as damage
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to the blood brain barrier, free oxygen radicals causing oxidative stress, and other
biochemical changes may be responsible for the onset of degenerative processes in the
brain inducing dementia and other chronic diseases (Lye and Shores, 2000; Zhang et al.,
2000).

Adult Neurogenesis
In 1928 Ramon y Cajal proposed the idea that the brain loses the ability of growth
and cellular regeneration after development (y Cajal, 1959). However, there is now
overwhelming evidence indicating certain areas of the mammalian brain retain the ability
to regenerate neural and glia cells. Evidence of adult neurogenesis in mammalian brain is
largely found in rodent studies although it is also shown in many primate studies
including humans (Rakic et al., 1985).

The most active neurogenic regions in the adult mammalian brain are restricted to
the SVZ of the lateral ventricles and the subgranular zone (SGZ) of the DG in the
hippocampus (Lois and Alvarez-Buylla, 1993; Altman and Das, 1965). Some studies
have also reported evidence of adult neurogenesis in the neocortex, striatum, and
hypothalamus although these findings are controversial (Cameron and Dayer, 2008;
Gould, 2007).

The neurogenic process starts with the NSC proliferation, giving rise to more
NSC and sometimes asymmetrically dividing into NPC, which are more determined to
differentiate into either the neural or glial lineage (Gage, 2000). NSC division involves
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both asymmetric and symmetric division. During asymmetric division, one NSC divides
to produce one NSC and one NPC (Kriegstein and Alvarez-Buylla, 2009). Symmetric cell
division can be proliferative, where one NSC divides into two identical NSCs, or
differentative, where one NSC divides into two NPCs (Kriegstein and Alvarez-Buylla,
2009). NPC then migrate to their destinations where they can differentiate and have
functional potential. In the SVZ, most NPC migrate to the olfactory bulb, via the rostral
migratory stream, where they differentiate into olfactory interneurons (Gritti et al., 2002).
In the DG, migration is much more restricted, however, NPC do travel a short distance
from the SGZ to the granular cell layer, where they can differentiate into granular
neurons (Kempermann and Gage, 2000; van Praag et al., 2002). In both regions,
migration of the cells and extension of dendrites and axons is guided by extracellular
matrix molecules (Bovetti et al., 2007) and chemoattractive and repulsive molecules
similar to migratory signaling pathways of development (Wu et al., 1999).

In the DG, differentiation from NPC to mature functional granular neurons
involves transition through several cell types. The proliferation stage of neurogenesis
involves Type 1 and Type 2 progenitor cells. Type 1 cells, also called radial glial cells,
divide slowly and asymmetrically into Type 2 cells, and Type 2 cells divide rapidly into
more Type 2 cells or differentiate into neuroblasts (Bonaguidi et al., 2012). Neuroblasts
then differentiate into immature neurons which, if allowed to survive, mature into
granular neurons that extend their dendrites into the molecular layer and extend axons
into the correct area of the CA3 region of the DG (Figure 1.1, Aimone et al., 2014;
Hastings and Gould, 1999).
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In both the SVZ and DG, pre-existing neurons are continuously replaced by
newly generated neurons (Gage, 2000). In the DG, this amount of neuronal turnover
varies in different regions such as the superficial granular cell layer, where 50% of the
existing cells are replaced by late postnatal neurogenesis, and the deeper granular cell
layer, where almost all pre-existing granular neurons are replaced (Imayoshi et al., 2008).
The addition of these new neurons in the DG is significant enough to impact network
function and has been shown to be important in normal cognitive function and behavior
(Sun, 2016).

During the maturation period of immature neurons, when they are undergoing
morphological and physiological changes, their survival and potential for integration into
the existing network is modulated by experience and on-going activity of the animal
(Tashiro et al., 2007; Kee et al., 2007). Studies inhibiting adult neurogenesis in DG of
rodents show that although inhibition may not cause depletion of existing neuron
populations, it does retard the formation and integration of new neurons into the existing
population which causes defects in spatial memory learning tasks such as Morris Water
Maze (MWM) (Imayoshi et al., 2008; Jessberger et al., 2009). This supports the idea that
the role of neurogenesis in the DG is for modulation of existing neural networks for
hippocampal-dependent learning and memory functions, important during postnatal
cognitive development.
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Additionally, many studies show that cognitive function is affected by the level of
adult neurogenesis which can be modulated by environmental experience, activity, and
drugs, further confirming that adult neurogenesis plays an important role in hippocampaldependent learning and memory functions. Animals placed in enriched environment or
given physical exercise show increased levels of granule cell proliferation and improved
performance in spatial memory tasks such as MWM (Brown et al., 2003; Van et al.,
1999). Similar results have been found with exogenous administration of growth factors
such as Basic Fibroblast Growth Factor (bFGF) (Wagner et al., 1999; Sun et al., 2009).
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Figure 1.1. Adult neurogenic process in the dentate gyrus. Image extracted from
Aimone et al., 2014. Proliferation step involves Type 1 cells asymmetrically dividing into
neuroblasts by day three. By one week these neuroblasts become immature neurons,
which then enter a survival period to mature into integrated granular neurons extending
their dendrites into the molecular layer and axon into the CA3 region by 3-4 weeks.
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TBI Induced Neurogenesis
Modulation of adult neurogenesis has also been confirmed in TBI studies. This
TBI stimulated endogenous neurogenesis is a natural response of the brain to promote
repair (Sun, 2016). Although the exact mechanisms underlying the TBI-induced
neurogenic response are unclear, studies have reported the up-regulation of growth
factors such as Vascular Endothelial Growth Factor (VEGF), p75 NTR, bFGF, and
Epidermal Growth Factor (EGF) following injury may regulate this process (Lee and
Agoston, 2010; Catts et al., 2008; Sun et al., 2009; Sun et al., 2010). TBI animal models
have shown increased proliferation of new cells in both the DG and SVZ (Dash et al.,
2001; Rice et al., 2003). In the DG, cell proliferation peaks at 2 days post-injury
thereafter gradually declining and reaches baseline level at 14 days post-injury (Figure
1.2, Sun et al., 2005). In terms of differentiation and survival of new neurons, studies
have reported different results and these differences could be attributed to many different
experimental factors such as different injury models or species used (Sun et al., 2007;
Villasana et al., 2014). In the DG, almost half of all TBI-induced newly generated cells
are able to survive to 10 weeks post-injury and most of these cells become mature
neurons integrated into the functional hippocampal network, leading to cognitive
recovery (Figure 1.3, Sun et al., 2007). In TBI animal studies, newly generated cells take
about 14 days to fully mature and integrate into the functional network, which at that time
animals begin to show cognitive recovery in MWM test, and by 60 days their
performance is not significantly different from sham animals (Sun et al., 2007). This
structural and functional recovery, via the neurogenic response of the brain following
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injury, can be exogenously stimulated to promote regeneration and repair as a strategy for
TBI treatment.

Current developments for TBI treatment include different methods of further
stimulating neurogenesis following injury. Exogenous administration of growth factors
such as bFGF and EGF has shown increased proliferation in the DG and SVZ compared
to untreated animals after injury (Sun et al., 2009; Sun et al., 2010). Similar treatments of
other growth factors such as Insulin-like growth factor 1, brain-derived neurotrophic
factor, VEGF, and S100B in injured animals have shown increased generation of new
neurons and improved cognitive and functional recovery compared to untreated animals
(Carlson et al., 2014; Gao et al., 2009; Thau-Zuchman et al., 2010; Kleindienst et al.,
2005). Pharmacological agents have also been developed to target post-TBI neurogenesis
such as Cerebrolysin, 7,8-Dihydroxyflavone, LM11A-31, and carbamylated
erythropoietin, showing increased neurogenesis with improved cognitive and functional
recovery (Zhang et al., 2015; Chen et al., 2015; Shi et al., 2013; Xiong et al., 2011).
Simple exercise such as running or putting animals in an enriched environment can also
stimulate neurogenesis and improve recovery after injury (Gaulk et al., 2005; Piao et al.,
2013).
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Figure 1.2. Proliferation timeline in the dentate gyrus. Results image extracted from
Sun et al., 2005. The number of BrdU positive cells in the SGZ of the DG are shown at 2,
7, and 14 days after injury. Animals received I.P. injections of BrdU at 2, 7, or 14 days
after injury and were sacrificed 24 hours after the last injection. Injured juvenile and
injured adult groups show peak proliferation at 2 days post injury and no difference in
proliferation compared to sham animals at 14 days. Also, injured juveniles had almost
twice the proliferation level as that of the adults at 2 days post injury.
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Figure 1.3. New cells survive long time after injury. Results image extracted from Sun
et al., 2007. Animals received I.P. BrdU injections at 5 days post injury. Injured animals
show 4-fold increase of the number of BrdU cells at 5 days post injury. At 10 weeks post
injury the number of BrdU cells was 3-fold higher than sham animals indicating that a
significant number of BrdU cells survive even at 10 weeks post injury.
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Animal models of TBI
Our current understanding of TBI, mechanisms regulating damages, and
development of potential treatments can be attributed to the use of animal models of TBI.
To understand the heterogeneity of TBI, different animal models are in use that mimic
specific aspects about the injury and resulting damages. These various models include
fluid percussion injury (FPI), CCI, penetrating ballistic-like brain injury, weight-drop,
Blast, and repeated mild TBI (Xiong et al., 2013). The most popular and widely used
models are FPI and CCI.

Since TBI can be caused in various situations including car accidents, sports, and
military grounds, these models are set up to replicate primary and secondary injuries to
the brain. For example, the FPI models are designed to replicate focal cortical contusion
with diffuse subcortical neuronal injury, without skull fracture (Xiong et al., 2013). The
CCI model is designed to replicate mostly focal injury mechanisms (O'Connor et al.,
2011). These models bypass the skull fracture, which allows for specific replication of
injury aspects and control of injury parameters without randomized damages created by
skull fragments.

Both the CCI and FPI models allow for control of the injury causing parameters.
In the FPI model, injury severity can be controlled by the height of the pendulum, which
hits the fluid tube exerting a fluid pressure pulse to the brain (Kabadi et al., 2010). The
CCI model has an advantage over the FPI model in that it allows for more control of
parameters such as time, velocity, and depth of impact (O'Connor et al., 2011).
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Nevertheless, both models have been successfully used to reproduce TBI and also to
study the modulation of neurogenesis following injury.

TBI-induced Neuroinflammation
One of the several pathological conditions of TBI includes neuroinflammation.
The complexity of many different molecular interactions and signaling pathways
involved in neuroinflammation makes it difficult to elucidate the detailed mechanisms
regulating this condition (Morganti-Kossmann et al., 2002). However, studies have
reported that the immune system and central nervous system (CNS) resident glia cells are
involved in inflammatory immune response after injury (Morganti-Kossmann et al.,
2007). Although the CNS is considered to be unaffected by the immune system, the
disruption of the blood brain barrier after injury causes an increased expression of
endothelial adhesion molecules and disruption of endothelial tight junctions leading to
increased migration of immune cells such as leukocytes from systemic circulation into
the brain parenchyma via interaction of endothelial adhesion molecules with integrins on
the surface of leukocytes (Figure 1.4, Ziebell and Morganti-Kossmann, 2010; MorgantiKossmann et al., 2007). Tissue damage also triggers non-infection immune reactions that
are activated by the release of damage associated molecular pattern molecules (DAMPs)
from the injured tissue, which participate in the activation of the innate immune system
(Matzinger et al., 1994; Manson et al., 2004). TBI-induced neuroinflammation, however,
has been a controversial topic as studies suggest both beneficial and detrimental
outcomes (Morganti-Kossmann et al., 2002).
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Microgila, the resident immune cells of the CNS, are a major source of cytokine
and chemokine release after injury. Conflicting evidence has been reported about the role
of cytokines and chemokines, whether they promote repair functions or exacerbate the
damages (Morganti-Kossmann et al., 2002). Enhanced tumor necrosis factor (TNF) levels
in the brain after TBI has been associated with neurologic deficits, neuronal cell death,
and blood brain dysfunction (Shohami et al., 1999). On the other hand, TNF knockout
studies demonstrate that TNF may contribute to an early neurotoxic effect and a
neuroprotective effect later in post-traumatic phase (Scherbel et al., 1999). TNF also
triggers a rise in IL-6, which is a multifunctional factor that has anti-inflammatory
effects, neurotrophic properties, induces nerve growth factor, promotes neuronal
differentiation and survival, and counteracts excitotoxicity (Morganti-Kossmann et al.,
2001). This suggests that there is a feedback loop balancing the release of pro- and antiinflammatory cytokine release, further complicating the roles of these molecules
(Morganti-Kossmann et al., 2002). IL-10, another anti-inflammatory cytokine, is well
studied for its beneficial role in neuropathology and has also shown to diminish TNF
synthesis (Morganti-Kossmann et al., 2000). However, a study in human TBI showed that
high levels of IL-10 were associated with increased mortality (Bell et al., 1997). Other
cytokines that have shown this dual nature include TGF-β, IFN-γ, and IL-18 (FusterMatanzo et al., 2013). The complicated roles of these molecules may be a result of a
complex interplay of molecular signaling and a fundamental importance of timing and
concentration of their expression.

Neuroinflammatory Effects on Neurogenesis
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As for the effects of neuroinflammation on adult neurogenesis, whether it is
beneficial or detrimental, seems to depend on the magnitude and duration of the
inflammation (Fuster-Matanzo et al., 2013). Microglia play a critical role in the
regulation and balance of these effects. In the normal uninjured brain, microglia regulate
the balance of neurogenesis by releasing factors that instruct proliferated cells to
differentiate into neurons, survival of immature neurons, or phagocytosis of apoptotic
new cells (Sierra et al., 2010; Walton et al., 2006). Microglia are involved in releasing
both anti-inflammatory and pro-inflammatory molecules providing pro-neurogenic and
anti-neurogenic effects respectively (Fuster-Matanzo et al., 2013). However, there is
strong evidence suggesting that chronic-inflammation leads to decreased neurogenesis
through the accumulation of cytotoxic substances such as oxidative stress molecules and
pro-inflammatory cytokines (Choi et al., 2009). Over-activation of microglia disturbs the
homeostatic balance of pro- and anti-inflammatory cytokines inducing cell death
pathways and leading to neurodegenerative diseases such Alzheimer’s and multiple
sclerosis (Gao and Hong, 2008). Also, these apoptotic-mediating molecules are sustained
long after TBI (Raghupathi et al., 2000). These effects have also been demonstrated in
aging studies where aged mice have greater neurogenic deficits from neuroinflammation
(Russo et al., 2011). Studies have shown that age is a critical factor that determines the
level of endogenous neurogenesis as older animals show lower levels of neurogenesis
(Sun et al., 2005).

Although the immune response is a way for the body to restore homeostasis, after
TBI, a sustained immune activation can ultimately lead to the blockage of restoration and
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repair functions that otherwise could lead to a better outcome (Corps et al., 2015). These
studies suggest that despite the initial benefits of inflammation after TBI, chronic
inflammation may be detrimental to adult neurogenesis.
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Figure 1.4. Immune system involvement in TBI. Image extracted from Ziebell and
Morganti-Kossmann, 2010. Injury-induced blood brain barrier damage causes infiltration
of leukocytes into the brain parenchyma via interaction of endothelial adhesion molecules
with integrins on the surface of leukocytes, which can cause immune activation and
inflammation in the brain.
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Hypothesis
In this study, we examine the differences in the neurogenic response following
TBI in the subacute and chronic TBI stage using the CCI and LFPI models. Post-TBI
cognitive decline or dementia is a significant issue. As hippocampal neurogenesis plays
an important role in cognitive function, we speculate that TBI may have a long lasting
effect on hippocampal neurogenesis, which may be affecting cognitive function.
Specifically, we propose that in the chronic TBI stage there is a decline of neurogenesis
below the baseline level and this decline is due to either the exhaustion of the NSC pool,
from over stimulation of symmetrical differentiative divisions during neurogenesis, or
persistent neuroinflammation.

Because TBI is such a complex and complicated neurological disorder with
impact on other neurological diseases, it is difficult to study TBI using one animal model.
Since TBI encompasses a vast array of complex mechanisms and each type of animal
model is used to study specific aspects of TBI, it is practical to use multiple different
animal models when studying TBI and treatments. However, in terms of studying TBIinduced neurogenesis, there are no studies that compare the levels of injury-induced
neurogenesis among different animal models. In this study we used two popular TBI
animal models, CCI injury and LFPI models, to study focal and diffuse injuries responses
respectively.
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Chapter 2 - Materials and Methods
Experimental Animals
All animals used in this study were 3 months old male Sprague-Dawley rats that
weighed around 300g and were purchased from Harlan Inc., Indiana. A total of 25 rats
were included in this study. All animals were housed in pair at the Virginia
Commonwealth University animal care facility and were given a 12 hour light/dark cycle
at room temperature with adequate food and water ad libitum. Proper maintenance and
animal care procedures were followed, which were approved by the Institution of Animal
Care and Use Committee (IACUC) of Virginia Commonwealth University and the Guide
for Care and Use of Laboratory Animals by the U.S. Department of Health and Human
Services.

Experimental Setup
Animals were divided into two groups. Group one included 15 total rats and
group two included 10 total rats. All animals received the same housing and care. Group
one animals included four animals that received LFPI, seven animals that received CCI
injury, and four sham animals. All group one animals were sacrificed 15 days after
injury. Group two animals included four LFPI animals, four CCI injury animals, and two
sham animals. All group two animals were given one BrdU injection 2 hours before
sacrifice and were sacrificed 3 months after injury. The experimental set up is also
described in Table 2.1.
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Table 2.1. Experimental Setup

Sham
LFPI
CCI
Sacrifice Time After Injury
BrdU Administration
Immunostaining
Hippocampus Size
Comparison

Group 1
4 Rats
4 Rats
7 Rats
15 Days

Group 2
2 Rats
4 Rats
4 Rats
3 months
2 Hours before
sacrifice
DCX, Ki67, DCX, Ki67, BrdU,
OX6, ED1
OX6, ED1
Cresyl violet
stained sections
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Table 2.1. Experimental setup. Animals were divided between Group 1 and Group 2.
Group 1 includes 4 shams, 4 LFPI, and 7 CCI rats, which were sacrificed 15 days after
injury. Hippocampal sections of these rat brains were used for DCX, Ki67, OX6, and
ED1 immunostaining. Group 2 included 2 shams, 4 LFPI, and 4 CCI rats, which received
BrdU injections 2 hours before sacrifice and were sacrificed 3 months after injury.
Hippocampal sections of these rat brains were used for DCX, Ki67, BrdU, OX6, and ED1
immunostaining as well as hippocampal size comparison.
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Surgical procedures
Animals were randomly assigned to receive LFPI, CCI, or Sham injuries. Before
surgery, all surgical tools and instruments were sterilized and aseptic procedures were
followed during surgery. Animals were first put in a Plexiglas chamber with 5%
isoflurane to be anesthetized. Once the animal was unconscious, the animal’s head was
shaved to remove excess fur. Then the animal’s head was fixed in a stable position in a
stereotaxic apparatus while the animal was intubated and kept anesthetized throughout
surgery with 2.5% isoflurane in a gas mixture of 30% O2 and 70% N2. Betadine was
applied to sterilize the head at the surgical site. Paralube ointment was applied to both
eyes of the animal to prevent the eyes from drying. Using a scapula, a midline incision
was made on the head and hemostats were used to retract the skin on both sides of the
head to expose the skull. Connective tissue was removed by rubbing the skull with
sterilized cotton tip applicators. A 4.0 mm craniotomy was made half way between the
lambda and bregma sutures on the left parietal bone using a trephine and a Dremel drill
fitted with a small dental drill bit. After cutting the bone, it was removed and any bone
shards were removed from the craniotomy. All animals, including shams received the
above surgical procedures. For LFPI and CCI injury animals, appropriate injuries were
performed as described below. After surgery, the surgical incision was sutured in a
simple continuous pattern using a sterilized stainless steel suture needle and a 5-0
polyamide surgical suture. Lidocaine hydrochloride jelly, which is a local anesthetic, and
a triple antibiotic ointment were applied to the closed suture. Then, the isoflurane was
turned off and intubation was removed. The animal was monitored until it regained
normal breathing pattern. The animal’s cage was lined with surgical drape and once the
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animal righted, it was placed back into the cage and observed for three hours before
returning to the animal housing facility.

Lateral Fluid Percussion Injury
A total of 8 animals received LFPI in this study. After the craniotomy, a Luer lock
hub was cemented over the craniotomy using cyanoacrylic. Dental acrylic was used to
seal the base around the hub and allowed to dry. To test the seal, the hub was filled with
0.9% saline solution, which also served as a medium for the injury pulse from the FPI
device. Then, for 4 minutes, the isoflurane rate was reduced to 1%. During this time the
FPI device (Figure 2.1, Thompson et al., 2005) was prepared by measuring the height of
the pendulum that was needed to produce the target pressure pulse. This was done by
calibrating the device by repeated test uses to produce pressure pulses around a target
value of 2.0 atm. The pressure was measured by an oscilloscope (Tektronix) and a
pressure transducer amplifier, which were connected to the FPI device. The isoflurane
was turned off and the Luer lock hub on the animal was connected to the injury device
and the injury was administered. Then the hub was disconnected from the injury device
and the animal was returned to the surgical preparation area. The Luer lock hub and
acrylic base were detached from the animal’s head and the animal was placed on the
surgical mat. The animal was observed until it righted and the righting time was recorded.
Once the animal regained normal breathing, it was placed back on to the stereotaxic
frame and was anesthetized with 5% isoflurane before the surgical site was sutured.
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Figure 2.1. Lateral fluid percussion injury setup. (A) All injuries were made on the
left hemisphere in the middle of bregma and lambda sutures as represented in this image.
(B) This cartoon depicts the LFPI device used in this study and the position of the animal
during injury.
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Controlled Cortical Impact Injury
A total of 11 animals received CCI injury in this study. After the craniotomy,
animals were kept anesthetized. A Leica Benchmark Stereotaxic Impactor was connected
to the stereotaxic frame (Figure 2.2, Galgano et al., 2015). The 3 mm rigid impactor tip
was positioned above the craniotomy and the zero point of impact was obtained by
lowering the tip of the impactor until it touched the dura mater. The tip was driven by an
electromagnetic piston and moved at 4 m/sec and remained on the tissue for 500 ms. A
2.5 mm depression in the tissue was set to cause a moderate level of focal injury. After
the tip retracted, it was raised away from the animal. The animal was then sutured and
monitored for normal breathing before returning to home cage.
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Figure 2.2. CCI device. Photographs representing the (A) Controlled Cortical Impact
injury device and (B) position of the animal during injury.
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BrdU injections
BrdU (Sigma-Aldrich Co.), a thymidine analog that incorporates into DNA during
cell division, is used to permanently label dividing cells. Group 2 animals received one
dose (50 mg/kg of body weight) via intraperitoneal (I.P.) injection at 2 hours before
sacrifice.

Sacrifice and Tissue Processing
Group one animals were sacrificed 15 days after injury while group two animals
were sacrificed 3 months after injury. Each animal was placed in a Plexiglas chamber
with 5% isoflurane and deeply anesthetized. The animal was taken out and a surgical
gauze pad soaked in 100% isoflurane was placed on the animals nose to keep it
anesthetized while it was transcardially perfused with 400 mL phosphate-buffered saline
(PBS) and then with 400 mL of 4% paraformaldehyde in PBS fixative. The brains were
removed and stored at 4°C in 4% paraformaldehyde in PBS fixative. After 48 hours, the
brains were sliced into 60 µm coronal sections using a vibratome (Leica). The sections
were stored in 24 well plates filled with 0.01% sodium azide in PBS and stored at 4°C.
Brain sections were used as needed for different immunostaining protocols.

BrdU Immunostaining
Six sequential hippocampal brain sections from each brain of group two animals
were selected for BrdU immunostaining. Sections were first washed in 1X PBS two times
for five minutes each. Then they were incubated in a denatured solution with 50%
formamide, 37.5% H2O, and 12.5% 20X saline sodium citrate (SSC) buffer for one hour
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at 65°C. Then the sections were rinsed in 2X SSC two times for 5 minutes each, and
further denatured in 2N hydrochloric acid for 30 minutes at 37°C. Then they were rinsed
with 1X PBS two times for 5 minute each, and placed in 3% hydrogen peroxide for one
hour. The sections were then rinsed with 0.3% Triton X-100 in 1X PBS (washing buffer)
for 10 minutes and placed in 5% normal horse serum in washing buffer (blocking buffer)
overnight at 4°C. Then the sections were placed in the BrdU antibody solution for 48
hours at 4°C. The antibody solution was prepared with monoclonal mouse anti-BrdU
antibody (Dako) diluted in blocking buffer at a 1 to 200 dilution. The sections were then
allowed to come back to room temperature and rinsed in washing buffer three times for
10 minutes each, before placing them in blocking buffer for three hours at room
temperature. Then the sections were placed in secondary antibody solution overnight at
4°C. This solution was prepared with the Biotin-conjugated anti-mouse IgG antibody
(Vector) diluted in blocking buffer at a 1 to 200 dilution. The sections were then allowed
to come back to room temperature and rinsed in washing buffer three times for 10
minutes each, before placing them in Avidin-biotin Complex reagent for two hours at
room temperature. This solution was prepared 30 minutes before use from the Avidinbiotin Complex kit (Vector Labs, Burlingame, CA) and diluted in 1X PBS at a 1 to 200
dilution. Then the sections were rinsed in washing buffer three times for 10 minutes each,
before placing them in 3,3’ diaminobenzadine tetra-hydrochloride (DAB) (Sigma)
solution. Once the sections were properly stained by the reaction, which was noted by
visible stained cells under the microscope, the sections were rinsed with 1X PBS three
times and mounted onto glass slides and allowed to air dry. Then they were
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counterstained with 0.1% cresyl violet, dehydrated through gradient ethanol and cover
slipped with Permount.

DCX, Ki67, OX6, ED1 Immunostaining
Sequential brain sections of all animals were processed for Doublecortin (DCX),
Ki67, OX6, and ED1 immunostaining. Similar steps were taken as described in BrdU
immunostaining, with the exception of denaturing procedure. After sections were rinsed
with PBS, they were directly placed in 3% hydrogen peroxide solution for one hour,
thereafter, BrdU immunostaining protocol was followed. For DCX immunostaining, the
primary antibody solution was prepared with polyclonal goat anti-DCX (1:1000, Santa
Cruz) and the secondary antibody solution was prepared with the Biotin-conjugated antigoat IgG antibody (1:200, Vector). For Ki67 immunostaining, the primary antibody
solution was prepared with rabbit anti-Ki67 (1:500, Abcam) and the secondary antibody
solution was prepared with Biotin-conjugated anti-rabbit IgG antibody (1:200, Vector).
For OX6 immunostaining, the primary antibody solution was prepared with mouse anti
rat MHC Class II OX6 antibody (1:1000, AbD Serotec) and the secondary antibody
solution was prepared with the Biotin-conjugated anti-mouse IgG antibody (1:200,
Vector). For ED1 immunostaining, the primary antibody solution was prepared with
mouse anti rat ED1 (1:1000, AbD Serotec) and the secondary antibody solution was
prepared with the Biotin-conjugated anti-mouse IgG antibody (1:200, Vector).

Densitometry
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The intensity of OX6 and ED1 staining was quantified by densitometry analysis
using Image J program. Briefly, images of selected regions of OX6 or ED1 stained
section was taken using the 4x objective on an inverted light microscope (1X71,
Olympus) and Olympus controller program. Images were taken with automatic adjusted
white balance, and exposure was set to produce the best image. Exposure was kept same
for all sections of animal brains to be compared. ImageJ program was used to measure
the optical density of the staining in a selected region of interest at a 0.621 pixels/um
scale. The images were first converted to a RGB stack image. The threshold for detection
was determined by selecting automatically according to the image exposure. For each
brain, two sections were used and the average of measurements was taken. Measurements
were recorded as percentage of selected area stained.

Stereology
All stained hippocampal sections were observed under an inverted light
microscope (1X71, Olympus) microscope for quantifying the number of stained cells. For
all cell counting, the Visiopharm program (Olympus) was used. First, a 4x objective was
used to outline the region of interest. The stereological optical fractionator method was
used to count the number of stained cells in the outlined region. For Ki67 and BrdU
stained sections, the granular zone (GZ), which includes the SGZ and granular cell layer
(GCL), were outlined. For DCX stained sections, cells were separately counted in the
SGZ plus inner 1/3 GCL, middle 1/3 GCL, and outer 1/3 GCL. To derive the total DCX
positive cell count of the GZ, cell counts of following three regions were added: the SGZ
plus inner 1/3 GCL, middle 1/3 GCL, and inner 1/3 GCL. For Brdu, Ki67, and DCX
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sections, stained cells were also counted in the hilus region. Cells outside of the optical
dissector counting frame were omitted. The dissector height (h) was set to 15 µm.
Measuring the focal plane at five different locations on each section and then taking the
average, the average thickness (t) of each brain section was calculated. These averages
were then averaged for the total five sections per brain. Total cell counts (n) were
estimated to be n= ΣQ ¯· (t/h)(1/asf)(1/ssf), were ΣQ ¯ represents the number of counted
cells. asf is the average sampling fraction and because the entire region was counted in
these sections, it is set to one. ssf is the sample sectioning fraction and it is set to 0.125
because five sections were used from each brain, representing 1/8 of the total
hippocampus.

Hippocampal Size
To examine the injury-induced change of the hippocampus size, the ipsilateral and
contralateral hippocampal perimeters were measured using the Visiopharm program.
Cresyl violet stained sections from group two animal brains were observed under the
light microscope. The ipsilateral and contralateral hippocampi were separately outlined
using a 4X objective and perimeter of the outline was obtained. Due to inter-animal
variability of brain structures, we compared ipsilateral to contralateral hippocampi within
the same animal by taking a percent ratio of ipsilateral to contralateral hippocampal
perimeters. For each animal brain, 5 sections were used and their measurements were
averaged to calculate the hippocampal size percent change of each animal.

Statistical Analysis
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We performed One-Way ANOVA using SPSS software to determine statistical
significant difference of three injury groups, sham, CCI injury, and LFPI, in all
experiments. To compare pairwise statistical significance of any two groups, we
performed a post hoc Fisher Least Significant Difference (LSD) test. A p value of 0.05 or
less was considered statistically significant.
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Chapter 3 - Results
The purpose of this study was to evaluate the differences in TBI-induced
neurogenic responses in subacute and chronic-TBI using different TBI animal models.
Two popular TBI animal models, CCI and LFPI, were compared at two different injury
time points, 15 days after injury and 3 months after injury. The degree of neurogenic
difference was evaluated by comparing levels of proliferation, generation of new
neurons, and neuroblast migration after injury in the DG.

Experiment 1. TBI-Induced Subacute and Chronic Proliferation
We used the cell proliferation markers Ki67 and BrdU to identify newly
proliferating cells after injury in three groups: sham, CCI, and LFPI groups. Ki67 is a
popular marker for proliferating cells because during interphase the Ki67 protein is
located in the nucleus whereas during the mitotic cell phases it is relocated to the surface
of the chromosomes where it can be detected by Ki67 antibodies (Scholzen and Gerdes,
2000). We also used BrdU, which is a thymidine analogue that incorporates into
replicating DNA during the S phase of cell cycle, taking place of thymidine, and can later
be detected by BrdU antibodies in cells that were proliferating during the time of BrdU
incorporation (Kee et al., 2002).

Proliferative responses in Subacute-TBI
At 15 days after injury, we observed similar proliferative levels in all three groups
(Figure 3.1) and stereological quantification demonstrated that the number of Ki67
positive cells between the three groups in the granular zone and hilus regions of the DG
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remained relatively similar (Figure 3.2). This was true for both ipsilateral and
contralateral side. We used One-Way ANOVA to compare statistical significant
difference of all three groups and found no significant difference in the ipsilateral GZ
(p=0.325), ipsilateral hilus (p=0.465), contralateral GZ (p=0.826), and contralateral hilus
(p=0.376) regions of the three groups.
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Figure 3.1. Cell proliferation at 15 days after injury. Images of a coronal section of
Sprague Dawley rat brain showing Ki67 staining pattern of the ipsilateral dentate gyrus.
The arrows indicate Ki67 positive cells. Using the (A) 4X objective the entire staining
pattern of the dentate gyrus can be seen and using the (B) 40X objective the individual
stained cells are identified. This staining pattern is consistent in all injury groups
indicating similar levels of proliferation.

46

A.

Proliferation in GZ 15 Days Post
Injury
2500

Ki76+ Cells

2000
1500

Sham
CCI

1000

LFPI

500
0
Ipsilateral

B.

Contralateral

Proliferation in Hilus 15 Days Post
Injury
900
800

Ki67+ Cells

700
600
500

Sham

400

CCI

300

LFPI

200
100
0
Ipsilateral

Contralateral

47

Figure 3.2. Quantification of Ki67 positive cells at 15 days after injury. The number
of Ki67 positive cells in the dentate gyrus of ipsilateral and contralateral sides of the
injury were quantified in the sham, CCI, and LFPI injury groups. At 15 days after injury,
the level of proliferation in the (A) GZ was not significantly different in injured groups
from sham animals. This was also true for proliferation levels in the (B) hilus region.
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Proliferative responses in Chronic-TBI
To understand long-term effects of TBI on adult neurogenesis, we examined the
level of proliferation at 3 months after injury. In our results, we did not observe a
difference in the level of proliferation in injured animals compared to sham animals at 3
months after injury (Figure 3.3). Stereological quantification analysis using One-Way
ANOVA demonstrated that there was no significant difference in the levels of Ki67
positive cells in the ipsilateral (IP) and contralateral (CT) dentate gyrus of injury and
sham animals (IP: GZ p=0.838, hilus p=0.605; CT: GZ p=0.885, hilus p=0.785) (Figure
3.4). To further verify these findings, we used another cell proliferation marker, BrdU, to
label proliferating cells, and also found no difference in proliferation in sham and injured
groups. Stereological quantification analysis demonstrated that there was no significant
difference in the levels of BrdU positive cells in the ipsilateral (IP) and contralateral (CT)
dentate gyrus of injury and sham animals (IP: GZ p=0.438, hilus p=0.143; CT: GZ
p=0.627, hilus p=0.371) (Figure 3.5).
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Figure 3.3. Cell proliferation at 3 months after injury. Images of coronal sections of
Sprague Dawley rat brain showing Ki67 and BrdU staining patterns of the ipsilateral
dentate gyrus. The arrows indicate stained positive cells. Using the (A) 4X objective, the
Ki67 staining pattern of the entire dentate gyrus can be seen and using the (B) 40X
objective the individual stained cells are identified. The observed Ki67 staining pattern is
consistent in sham, CCI injury, and LFPI animals, indicating similar levels of
proliferation. Immunolabeled images of BrdU staing using (C) 4X objective to show the
entire dentate gyrus and (D) 40X objective to show individual stained cells also indicate
consistent proliferation levels in sham, CCI injury, and LFPI animals.
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Figure 3.4. Quantification of Ki67 positive cells at 3 months after injury. The number
of Ki67 positive cells in the dentate gyrus of ipsilateral and contralateral sides of the
injury were quantified in the sham, CCI, and LFPI injury groups. At 3 months after
injury, the level of proliferation in the (A) GZ was not significantly different in injured
groups from sham animals. This was also true for proliferation levels in the (B) hilus
region.
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Figure 3.5. Quantification of BrdU positive cells at 3 months after injury. The
numbers of BrdU positive cells in the ipsilateral and contralateral dentate gyrus were
quantified in the sham, CCI, and LFPI injury groups. At 3 months after injury, the level
of proliferation in the (A) GZ was not significantly different in injured groups from sham
animals. This was also true for proliferation levels in the (B) hilus region.
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Experiment 2. TBI-Induced Generation of New Neurons
After proliferation, surviving cells in neurogenic regions differentiate into either
neuronal or glial cell lineage. Cells that become determined for a neuronal lineage
express certain biomarkers including DCX. To determine the impact of TBI on the
generation of new neurons, we used the DCX antibody to label newly generated neurons.
DCX is a microtubule binding protein expressed in immature neurons and migrating
neuroblasts in neurogenic regions of the adult mammalian brain (Brown et al., 2003). We
compared levels of newly generated neurons at 15 days after injury and 3 months after
injury in the DG of animals that received sham, CCI, or LFPI injury.

Generation of New Neurons in Subacute-TBI
In our results, we observed an increase in the number of newly formed neurons at
15 days after injury in the ipsilateral dentate gyrus of the injured animals compared to
sham animals (Figure 3.6). We used One-Way ANOVA to compare significant
difference of all three groups and found statistically significant difference of the levels of
DCX positive cells in the ipsilateral GCL (p=0.002) and ipsilateral hilus region (p=0.001)
(Figure 3.7). We used a post hoc LSD test to determine pair wise significance of the
group means, which revealed that although there was a significant increase of DCX
positive cells in the ipsilateral GCL of injured animals compared to sham (sham vs. CCI,
p=0.001; sham vs. LFPI, p=0.015), there was no significant difference between the CCI
injury and LFPI groups (p=0.061). In the ipsilateral hilus region, a pairwise comparison
of each injury group to sham showed significant increase of DCX positive cells (sham vs.
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CCI, p<0.001; sham vs. LFPI, p=0.03) and CCI injury animals had significantly more
DCX positive cells than LFPI animals (p=0.005).
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Figure 3.6. Generation of new neurons at 15 days after injury. Images of a coronal
section of Sprague Dawley rat brain showing DCX staining pattern of the ipsilateral
dentate gyrus. The arrows indicate DCX positive cells. In (A) sham animals, there is less
observable DCX staining compared to (B) CCI injury and (C) LFPI. To determine
neuronal migration, (D) the GZ was divided into three regions, the SGZ and 1/3 of the
inner GCL, middle 1/3 of the GCL, and outer 1/3 of the GCL as shown.
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Figure 3.7. Quantification of DCX positive cells at 15 days after injury. In the (A)
ipsilateral GZ, both types of injuries resulted in significantly higher level of DCX
positive cells indicating more generation of new neurons compared to sham animals
(sham vs. CCI, p=0.001; sham vs. LFPI, p=0.015). In the (B) ipsilateral hilus region,
both types of injuries resulted in significantly higher level of DCX positive cells
compared to sham animals (sham vs. CCI, p<0.001; sham vs. LFPI, p=0.03), and the CCI
injury had a significantly higher number DCX positive cells compared to LFPI (p=0.005)
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Differences in neuronal migration was determined by using the Visiopharm
program to trace and divide the GZ into 3 regions, the SGZ plus inner 1/3 GCL, middle
1/3 of the GCL, and outer 1/3 of the GCL, and count the number of DCX positive cells in
each region (Figure 3.6). Stereological quantification demonstrated that both types of
injuries induced an increased number of DCX positive cells in the ipsilateral SGZ plus
inner 1/3 GCL, but only CCI injury induced an increase of DCX positive cells in the
ipsilateral middle 1/3 of the GCL, and ipsilateral outer 1/3 of the GCL. Using a post hoc
LSD test to compare pairwise significance, we found that in the SGZ plus inner 1/3 GCL,
each type of injury compared to sham had a statistically significant increase in DCX
positive cells (sham vs. CCI, p=0.005; sham vs. LFPI, p=0.021), but there was no
significant difference between CCI and LFPI groups (p=0.418) (Figure 3.8). In the
ipsilateral middle 1/3 GCL, we found that CCI injury produced a statistically significant
increase in DCX positive cells compared to sham and LFPI (sham vs. CCI, p<0.001; CCI
vs. LFPI, p<0.001), but there was no significant difference between sham and LFPI
groups (p=0.52) (Figure 3.8). In the ipsilateral outer 1/3 GCL, we found the same pattern
of increase in DCX positive cells where CCI injury produced a statistically significant
increase compared to sham and LFPI (sham vs. CCI, p=0.034; CCI vs. LFPI, p=0.021),
but there was no significant difference between sham and LFPI groups (p=0.948) (Figure
3.8).
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Figure 3.8. Migration of neuroblasts at 15 days after injury. In sham and injured
animals, majority of the DCX positive cells of the GZ were located in the (A) SGZ plus
inner 1/3 GCL, with a significantly higher number of DCX positive cells in injured
animals compared to sham (sham vs. CCI, p=0.005; sham vs. LFPI, p=0.021) and no
significant difference between CCI injury and LFPI groups (p=0.418). In the (B) middle
1/3 GCL, CCI injury resulted in a significantly higher number of DCX positive cells
compared to sham and LFPI (sham vs. CCI, p<0.001; sham vs. LFPI, p=0.52; CCI vs.
LFPI, p<0.001). Also in the (C) outer 1/3 GCL, CCI injury resulted in a significantly
higher number of DCX positive cells compared to sham and LFPI (sham vs. CCI,
p=0.034; sham vs. LFPI, p=0.948; CCI vs. LFPI, p=0.021).
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Generation of New Neurons in Chronic-TBI
To further evaluate long-term effects of TBI on adult neurogenesis, we examined
the generation of new neurons at 3 months after injury by DCX immunolabeling. In our
results, we observed a decrease in the number of newly formed neurons at 3 months after
injury in the ipsilateral and contralateral DG of the injured animals compared to sham
animals (Figure 3.9). Stereological quantification analysis demonstrated that injured
animals and sham animals had statistically different levels of DCX positive cells in the
ipsilateral GZ (p=0.002), contralateral GZ (p=0.016), and ipsilateral hilus region
(p=0.001) (Figure 3.10). Although we saw an observable difference between the three
groups in the contralateral hilus region, the data was not statistically different. A pairwise
comparison using post hoc LSD between two groups reveled that there was a significant
decrease of DCX positive cells in the ipsilateral and contralateral GZ of injured animals
compared to sham (IP: sham vs. CCI p=0.001, sham vs. LFPI p=0.002; CT: sham vs.
CCI p=0.009, sham vs. LFPI p=0.013), however, there was no significant difference
between the CCI injury and LFPI groups (IP: p=0.781; CT: p=0.823) (Figure 3.10). In
the ipsilateral hilus region, a pairwise comparison of each injury group to sham revealed
a statistically significant decrease of DCX positive cells in animals that received LFPI
(sham vs. LFPI, p=0.006) but not in animals that received CCI injury (sham vs. CCI,
p=0.118) (Figure 3.10). There was also no statistical difference between the two types of
injuries (CCI vs. LFPI, p=0.097).
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Figure 3.9. Generation of new neurons at 3 months after injury. Images of a coronal
section of Sprague Dawley rat brain showing DCX staining pattern of the ipsilateral
dentate gyrus. The arrows indicate DCX positive cells. In (A) sham animals, there are
more observable DCX stained cells compared to (B) CCI injury and (C) LFPI.
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Figure 3.10. Quantification of DCX positive cells at 3 months after injury. In the (A)
ipsilateral and contralateral GZ, both types of injuries resulted in significantly lower
levels of DCX positive cells indicating less generation of new neurons compared to sham
animals (IP: sham vs. CCI p=0.001, sham vs. LFPI p=0.002; CT: sham vs. CCI p=0.009,
sham vs. LFPI p=0.013). In the (B) ipsilateral hilus region, animals that received LFPI
resulted in significantly lower level of DCX positive cells compared to sham animals
(sham vs. LFPI, p=0.006).
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Differences in neuronal migration were determined by dividing the GZ into 3
regions as previously described (Figure 3.6). Stereological quantification demonstrated
that both types of injury groups had reduced number of DCX positive cells in the
ipsilateral and contralateral SGZ plus inner 1/3 GCL and middle 1/3 GCL compared to
sham. Using a post hoc LSD pairwise comparison, in the ipsilateral and contralateral
SGZ plus inner 1/3 GCL, we found that each type of injury compared to sham had a
statistically significant decrease in DCX positive cells (IP: sham vs. CCI p=0.001, sham
vs. LFPI, p=0.002; CT: sham vs. CCI p=0.011, sham vs. LFPI, p=0.018), but there was
no significant difference between CCI and LFPI groups (IP: CCI vs. LFPI p=0.676; CT:
CCI vs. LFPI p=0.782) (Figure 3.11). In the ipsilateral and contralateral middle 1/3
GCL, we also found that each type of injury compared to sham had a statistically
significant decrease in DCX positive cells (IP: sham vs. CCI p=0.011, sham vs. LFPI,
p=0.001; CT: sham vs. CCI p=0.026, sham vs. LFPI, p=0.008), but there was no
significant difference between CCI and LFPI groups (IP: CCI vs. LFPI p=0.1; CT: CCI
vs. LFPI p=0.5) (Figure 3.11). In the ipsilateral and contralateral outer 1/3 GCL, we did
not find a statistical difference in DCX positive cells in the three groups (IP: p=0.878;
CT: p=0.996) (Figure 3.11).
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Figure 3.11. Migration of neuroblasts at 3 months after injury in the dentate gyrus.
In sham and injured animals, majority of the DCX positive cells of the GZ were located
in the (A) SGZ plus inner 1/3 GCL, with a significantly higher number of DCX positive
cells in Sham animals compared to injured animals (IP: sham vs. CCI p=0.001, sham vs.
LFPI, p=0.002; CT: sham vs. CCI p=0.011, sham vs. LFPI, p=0.018). In the (B) middle
1/3 GCL, Sham animals had a significantly higher number of DCX positive cells
compared to injured animals (IP: sham vs. CCI p=0.011, sham vs. LFPI, p=0.001; CT:
sham vs. CCI p=0.026, sham vs. LFPI, p=0.008). In the (C) outer 1/3 GCL, there was no
difference in the number of DCX positive cells between any group.
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Experiment 3. Factors Which Are Associated to Post-TBI Neurogenesis
From experiments 1 and 2, our results indicate that TBI does not have an effect on
the level of proliferation in the subacute and chronic-TBI stage. However, we did find
that TBI does reduce the level of new neuron generation in the chronic stage, which is
opposite of that in the subacute TBI stage. To investigate mechanisms that maybe
associated to this change in neurogenesis in the chronic TBI stage, we examined
neuroinflammatory responses of subacute and chronic TBI. We used two TBI animal
models, CCI injury and LFPI, to study focal and diffuse injury effects at 15 days after
injury and 3 months after injury. Inflammatory response was examined by markers for
microglial activation in the brain. We used ED1 antibody to label ED1 proteins expressed
in activated microglia that become phagocytic in the rat CNS during an inflammatory
response (Damoiseaux et al., 1994). We also used the OX6 (anti-MHC class II) antibody
to identify immunoreactive cells in the CNS. We checked for inflammation in the cortex,
dentate gyrus, and thalamus.

Inflammation in subacute-TBI
At 15 days after injury, sham animals showed only scant amount of inflammation
in the brain as detected by ED1 staining in the thalamus and OX6 staining in the DG.
However, using both inflammatory markers, we show that injured animals had a
significant inflammatory response in the ipsilateral side of injury in the cortex, dentate
gyrus, and thalamus (Figure 3.12).
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ED1 staining in the cortex revealed that CCI injured animals had a staining
optical density of 10% +/- 1.8%, LFPI animals had a staining optical density of 14.5% +/11%, and both injury groups were not significantly different from each other (p=0.531)
(Figure 3.13). In the dentate gyrus, CCI injured animals had a staining optical density of
4.7% +/- 3.3%, LFPI animals had a staining optical density of 0.57% +/- 0.28%, and both
injury groups were significantly different from each other (p=0.002) (Figure 3.13). In the
thalamus, sham animals had a staining optical density of 0.2% +/- 0.03%, CCI injured
animals had a staining optical density of 2.7% +/- 1.8%, LFPI animals had a staining
optical density of 9.3% +/- 1.17%. Both injury groups had significantly more
inflammation in the thalamus compared to sham (sham vs. CCI, p<0.038; sham vs. LFPI,
p<0.001) and both injury groups were significantly different from each other (p<0.001)
(Figure 3.13). Both injury groups produced different inflammatory responses in the
ipsilateral dentate gyrus and thalamus, with CCI injured animals having a more ED1
staining in the dentate gyrus and LFPI animals having more ED1 staining in the
thalamus.

Similar trends were found with OX6 staining. In the cortex, CCI injured animals
had a staining optical density of 2.3% +/- 0.98%, LFPI animals had a staining optical
density of 12.5% +/- 9.9%, and both injury groups were significantly different from each
other (p=0.016) (Figure 3.14). In the dentate gyrus, sham animals had a staining optical
density of 0.29% +/- 0.29%, CCI injured animals had a staining optical density of 5.3%
+/- 2.4%, LFPI animals had a staining optical density of 1.8% +/- 1.57%. Although both
injury groups showed a greater inflammatory response in the DG compared to sham, only
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CCI injury group had a statistically significant increase (sham vs. CCI, p=0.004; sham vs.
LFPI, p=0.325). Also, both injury groups were significantly different from each other
(p=0.017) (Figure 3.14). In the thalamus, CCI injured animals had a staining optical
density of 11.3% +/- 2.76%, LFPI animals had a staining optical density of 26% +/1.76%, and both injury groups were significantly different from each other (p<0.001)
(Figure 3.14). Both injury groups produced different inflammatory responses in the
ipsilateral cortex, dentate gyrus, and thalamus, with CCI injured animals having a more
OX6 staining in the dentate gyrus, and LFPI animals having more OX6 staining in the
cortex and thalamus.
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Figure 3.12. ED1 and OX6 Staining Patterns In the Injured Brain. The top panel of
images shows ED1 inflammatory marker expression in the cortex, dentate gyrus, and
thalamus brain regions after CCI injury or LFPI. The bottom panel of images shows OX6
inflammatory marker expression in the cortex, dentate gyrus, and thalamus brain regions
after CCI injury or LFPI. Both inflammatory markers show inflammation in the injured
brains. There is a noticeable difference of inflammatory responses between CCI injury
and LFPI, with CCI injury producing more inflammation in the dentate gyrus, and LFPI
producing more inflammation in the thalamus.
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Figure 3.13. ED1 staining optical density at 15 days after injury. Optical density of
ED1 staining was used to measure level of inflammation in the (A) cortex, (B) dentate
gyrus, and (C) thalamus in sham and injured animals. Sham animals did not show ED1
staining in the cortex and DG and had scant inflammation in the thalamus. Animals of
both types of injuries showed inflammation in all ipsilateral structures. CCI injury
animals had significantly more inflammation in the dentate gyrus compared to LFPI
animals (p=0.002). LFPI animals had significantly more inflammation in the thalamus
compared to CCI injury animals (p<0.001).
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Figure 3.14. OX6 staining optical density at 15 days after injury. Optical density of
OX6 staining was used to measure level of inflammation in the (A) cortex, (B) dentate
gyrus, and (C) thalamus in sham and injured animals. Sham animals did not show OX6
staining in the cortex and thalamus and had scant inflammation in the DG. Animals of
both types of injuries showed inflammation in all ipsilateral structures. CCI injury
animals had significantly more inflammation in the dentate gyrus compared to LFPI
animals (p=0.017). LFPI animals had significantly more inflammation in the cortex
(p=0.016) and thalamus (p<0.001) compared to CCI injury animals.
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Inflammation in Chronic-TBI
At 3 months after injury, using both inflammatory markers we assessed
inflammatory responses in sham and injured animals. Injured animals showed more
inflammation compared to sham animals. In the cortex, sham animals did not show ED1
staining. In the ipsilateral cortex, CCI injured animals had a staining optical density of
4.55% +/- 1.73%, LFPI animals had a staining optical density of 6.38% +/- 4.88%, and
both injury groups were not significantly different from each other (p=0.507) (Figure
3.15). In the ipsilateral dentate gyrus, sham animals had a staining optical density of
0.16% +/- 0.03%, CCI injured animals had a staining optical density of 1.25% +/- 0.13%,
and LFPI animals had a staining optical density of 0.56% +/- 0.1%. Both injury groups
had significantly more inflammation in the dentate gyrus compared to sham (sham vs.
CCI, p<0.001; sham vs. LFPI, p=0.004) and CCI injury group had significantly more
inflammation compared to LFPI group (CCI vs. LFPI, p<0.001). Although ED1 staining
was detected in the contralateral dentate gyrus in sham and injured groups, One-Way
Anova comparison of the three groups showed no significant difference (p=0.604)
(Figure 3.15). In the ipsilateral thalamus, sham animals had a staining optical density of
0.42% +/- 0.07%, CCI injured animals had a staining optical density of 1.22% +/- 0.22%,
and LFPI animals had a staining optical density of 3.94% +/- 2.19%. LFPI group had
significantly more inflammation in the thalamus compared to sham and CCI injury group
(sham vs. LFPI, p=0.026; CCI vs. LFPI, p=0.032;), and CCI injury group was not
significantly different from sham (p=0.542). Although ED1 staining was detected in the
contralateral thalamus in sham and injured groups, One-Way ANOVA comparison of the
three groups showed no significant difference (p=0.739) (Figure 3.15).
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We also checked for inflammation in these brain regions with OX6 marker at 3
months after injury (Figure 3.16). In the cortex, sham animals did not show OX6
staining. In the ipsilateral cortex, CCI injured animals had a staining optical density of
3.08% +/- 1.61%, LFPI animals had a staining optical density of 3.7% +/- 3.5 %, and
both injury groups were not significantly different from each other (p=0.76). In the
contralateral cortex, OX6 staining was detected with both injury groups having
significantly more inflammation compared to sham (sham vs. CCI, p=0.035; sham vs.
LFPI, p=0.001) and LFPI group had significantly more inflammation compared to CCI
injury group (CCI vs. LFPI, p=0.002). In the dentate gyrus, sham and injured animals
showed OX6 staining, however, using One-Way ANOVA to compare all three groups,
we found no significant difference in ipsilateral and contralateral sides (IP: p=0.686; CT:
p=0.819). In the ipsilateral thalamus, sham animals had a staining optical density of
0.22% +/- 0.19%, CCI injured animals had a staining optical density of 0.2% +/- 0.08%,
and LFPI animals had a staining optical density of 1.24% +/- 0.31%. LFPI group had
significantly more inflammation in the ipsilateral thalamus compared to sham and CCI
injury group (sham vs. LFPI, p<0.001; CCI vs. LFPI, p<0.001;), and CCI injury group
was not significantly different from sham (p=0.936).
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Figure 3.15. ED1 staining optical density at 3 months after injury. Optical density of
ED1 staining was used to measure level of inflammation in the (A) cortex, (B) dentate
gyrus, and (C) thalamus in sham and injured animals. Injured animals showed
significantly more inflammation in ipsilateral cortex, dentate gyrus, and thalamus,
compared to sham animals. CCI injury animals had significantly more inflammation in
the dentate gyrus compared to LFPI animals (p<0.001). LFPI animals had significantly
more inflammation in the thalamus compared to CCI injury animals (p=0.032).
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Figure 3.16. OX6 staining optical density at 3 months after injury. Optical density of
OX6 staining was used to measure level of inflammation in the (A) cortex, (B) dentate
gyrus, and (C) thalamus in sham and injured animals. Injured animals showed
significantly more inflammation in the ipsilateral and contralateral cortex, and only LFPI
group showed significantly more inflammation in ipsilateral thalamus, compared to sham
animals.
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Experiment 4. Morphological Changes of the Hippocampus in Chronic-TBI.
Apart from cellular changes that happen after TBI, morphological changes of
overall brain structures such as the hippocampus have also been evaluated to assess
injury characteristics. The purpose of this experiment was to evaluate TBI-induced
morphological changes of the hippocampus in chronic-TBI stage using different TBI
animal models. The CCI and LFPI models were used to compare changes of the
hippocampal size after injury. The parameters of ipsilateral and contralateral hippocampi
were measured in injured and sham animal groups. Percent change was calculated by
taking a percentage of the ratio of ipsilateral to contralateral parameters.

In our results we found that only animals that received LFPI show reduction of
hippocampal size at 3 months after injury (Figure 3.17). These animals had a 12% +/7.64% reduction of ipsilateral hippocampal size (Figure 3.18). Animals that received
CCI injury and sham animals did not show changes in hippocampal size. Using One-Way
ANOVA to compare change in all groups, we found that there is a statistically significant
change (p=0.047). A post hoc LSD pairwise comparison, reveled that animals that
received LFPI had statistically reduced ipsilateral hippocampal size compared to sham
and CCI (Sham vs. LFPI, p=0.047; CCI vs. LFPI, P=0.027). Sham animals and CCI
injury animals were not statistically different (p=0.894).
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Figure 3.17. TBI-induced hippocampal size change at 3 months after injury. We
observed the ipsilateral and contralateral hippocampal size differences of sham, CCI
injury, and LFPI animal groups (scale bar= 900 µm). In sham animals, ipsilateral and
contralateral hippocampal sides were similar in size. In CCI injury animals, ipsilateral
hippocampus showed changes in shape but not in size compared to contralateral
hippocampus. In LFPI animals, we found observable reduction in ipsilateral hippocampus
size compared to contralateral hippocampus.
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Figure 3.18. Quantification of hippocampal size change at 3 months after injury.
Percentage of the ratio of ipsilateral to contralateral hippocampus perimeter reveals the
injury-induced change in ipsilateral hippocampal size. CCI injury animals and sham
animals do not have a change in ipsilateral hippocampus size. Only animals that received
LFPI show a reduction of ipsilateral hippocampal size with an average percent ratio of
88% +/- 7.64%, which is significantly different from sham animals (p=0.047) and CCI
injury animals (p=0.027).
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Chapter 4 - Discussion
TBI poses significant short and long-term challenges to millions of people around
the world (Zaloshnja et al., 2008). According to the CDC, majority of these patients are
either younger than 24 years old or over 65 years old. Clinical evaluations have shown
that TBI patients are more likely to develop many other neurological complications over
time than people without a TBI history (Koponen et al., 2002). Recently much attention
has been drawn to the relationship between TBI and dementia, as TBI patients commonly
develop neurodegenerative diseases later in life such as Alzheimer’s and CTE (Smith et
al., 2013). Over the past few decades we have learned a great deal about the mechanisms
that regulate TBI, however, a central question still remains unanswered; what is causing
these long-term TBI deficits?

One possibility could be that there is a change in adult neurogenesis in the chronic
TBI stage. In the past few decades we have discovered evidence of lifelong adult
neurogenesis, mainly in the SVZ and DG of the mammalian brain (Sun, 2016). Our lab
and many others have demonstrated that adult neurogenesis can be stimulated and one of
these stimuli is TBI (Sun et al., 2005; Gao and Chen, 2013). Following TBI, the brain
initiates endogenous neurogenic responses in an attempt to repair the physical damages.
Some studies suggest that TBI induced neurogenesis in the DG contributes to the shortterm spontaneous cognitive recovery seen in clinical patients (Sun et al., 2015; LeónCarrión and Machuca-Murga, 2001). Because the hippocampus is linked to cognitive
function and memory consolidation, TBI induced cellular changes in this structure may
explain cognitive and behavioral changes seen in TBI patients (Deng et al., 2009).
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However, the neurogenic stimulus following injury is not continuous and does not fully
repair the damages. Majority of these studies have focused on acute and subacute
neurogenic changes following TBI. For this reason, we investigated the neurogenic
changes from subacute to chronic-TBI stage, and the mechanisms that may regulate longterm neurogenic changes.

Summary of Results
To accurately study neurogenic responses after TBI, we used two different TBI
animal models. Previous studies have reported conflicting results of TBI-induced
neurogenic responses, particularly regarding cell differentiation and generation of new
neurons (Sun et al., 2005; Kleindienst et al., 2005; Kernie et al., 2001; Rice et al., 2003;
Gao and Chen, 2013). Some of these differences may be due to the use of different TBI
animal models. Because TBI is a complex process involving both focal and diffuse
injury, we used CCI and LFPI models to induce focal and diffuse injuries respectively,
and bring attention to any differences that can be attributed to using different animal
models. Brain tissue was collected 15 days after injury to evaluate subacute TBI, and 3
months after injury to evaluate chronic TBI.

In the subacute stage, TBI had no effect on the rate of proliferation in the GZ and
hilus region. However, DCX immunolabeling showed that TBI induced an increase in the
number of immature neurons in the ipsilateral side of injury in the GZ and hilus region.
Further analysis showed that CCI injury resulted in more immature neurons in the hilus
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than LFPI injury. Analysis of neural migration in the GZ revealed that TBI does cause
more lateral migration but this is specific to focal injury induced by the CCI model.

In the chronic stage of TBI, proliferation was no different after injury compared to
sham, similar to what we found in the subacute stage. Interestingly however, we found a
significant reduction in the generation of new neurons at 3 months after injury in the
ipsilateral and contralateral granular zone. In the hilus region a significant reduction was
seen only in the diffuse injury model in the ipsilateral side of injury. Neuronal migration
in the GZ was also reduced in chronic-TBI stage; however, this was only seen in the
middle 1/3 of the GCL.

To investigate the mechanisms that may regulate the activity of generating new
neurons in chronic-TBI, we examined neuroinflammation in the cortex, DG, and
thalamus at both subacute and chronic-TBI stage. In the subacute-TBI stage,
inflammation was seen only in the ipsilateral hemisphere of injured animals while sham
animals show no inflammatory responses. Also, CCI injury model induces a significantly
higher inflammatory response in the DG, while LFPI model induces a higher
inflammatory response in the thalamus, which is indicative of focal injury caused by CCI
model and diffuse injuries caused by LFPI model. In the chronic stage of TBI, we found a
similar trend in inflammatory response. We found low levels of inflammation in the DG
and thalamus of sham animals and significantly higher inflammatory responses in injured
animals in cortex, DG, and thalamus. These inflammatory results indicate that TBIinduced inflammation is persistent long after TBI injury.
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Further assessment of TBI induced changes in chronic stage involved
morphological analysis of the hippocampus. Our results indicate a changed morphology
of the hippocampus after injury that can be seen at 3 months after injury. CCI injury
model produced an observed change in shape of the ipsilateral hippocampus while LFPI
model caused shrinkage of the ipsilateral hippocampus.

Subacute-TBI neurogenic response
The TBI-induced neurogenic response involves all aspects of neurogenesis
including proliferation, differentiation, survival and integration (Sun, 2016). Our lab and
others have shown that TBI-induced proliferative activity peaks at 2 days post injury and
gradually returns to baseline by 14 days post injury (Sun et al., 2005; Gao and Chen,
2013). In this study, at 15 days after injury, we found baseline proliferation levels in
injured animals, consistent with previous reports. However, the ability of TBI to
stimulate an endogenous neurogenic response in the brain has been controversial. Most
studies agree that TBI induces an up-regulation in proliferation in the DG and SVZ (Sun
et al., 2005; Gao and Chen, 2013). However, discrepancies arise in discussion about the
fate of these newly proliferated cells. Some studies report that increased proliferation in
the neurogenic regions results in several fold increase of the number of new neurons that
can be seen as long as 60 days post injury (Sun et al., 2005; Kleindienst et al., 2005;
Kernie et al., 2001; Richardson et al., 2007). Other studies have found that TBI does not
change the production of new neurons (Rice et al., 2003; Gao and Chen, 2013) or may
even have a reductive effect on neuronal production (Rola et al., 2006). These
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discrepancies may be due to many factors including different injury models used,
assessment at different post injury time points, quantification methods, and/or human
error. In our results, we found that at 15 days after injury using either CCI or LFPI model,
TBI causes a significant increase in the number of immature neurons in the ipsilateral DG
of the adult rat brain. This is in disagreement with another study that used similar
approach, looking at the number of DCX positive cells after injury, to assess TBI-induced
generation of immature neurons, in which they report a significant decrease (Rola et al.,
2006). The difference in results may be due to different animals used as their study used
mice. Also, cell counting methods were different as they only examined the number of
DCX positive cells in the SGZ, excluding a major portion of cells that may have migrated
into the inner 1/3 GCL after injury. Other studies that have shown a TBI-induced increase
in the generation of new neurons, have not directly analyzed cell counts of immature
neurons after injury.

Chronic-TBI Neurogenic Response
TBI-induced proliferation involves a robust increase in cell divisions of NSC into
more NSCs and NPCs (Sun et al., 2005; Bonaguidi et al., 2012). We hypothesized that
the acute-TBI neurogenic stimulus would exhaust the NSC pool through rapid
symmetrical differentative cell divisions, where one NSC divides into two NPCs,
resulting in reduced proliferative activity over time. Our proliferation results using both
pulse BrdU paradigm and Ki67 staining at 3 months after injury however, did not match
our expectations, as we did not find a reduction of proliferative activity in chronic TBI,
indicating that the NSC pool may not be exhausted over time. Our results are inconsistent
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with a previous study that reported reduction of proliferating cells 2 month after injury
(Acosta et al., 2013). Although they used similar TBI model and immunohistochemical
staining procedures, their cell counting method involved only examining the number of
Ki67 positive cells in the SGZ, whereas we included proliferating cells of the entire
granular zone.

To fully understand chronic-TBI impact on neurogenesis, we also looked at the
generation of new neurons at 3 months after injury. Although proliferative activity is not
impacted by TBI in the chronic stage, our results show significant reduction in the
number of DCX positive cells, suggesting that TBI causes a long-term reduction in the
ability to generate new neurons in the DG. Studies have suggested that chronic
neuroinflammation may negatively regulate adult neurogenesis (Gao and Hong, 2008). In
a rodent TBI study, sustained neuroinflammation was detected more than 8 weeks postinjury and showed hippocampal cell loss and down-regulation of proliferation in the SGZ
of the hippocampus when compared to sham animals (Acosta et al., 2013). Considering
that TBI-stimulated hippocampal proliferation returns to baseline levels by 14 days postinjury, at 8 weeks post-injury the baseline neurogenic stimulus may not be strong enough
to overcome the negative effects of chronic-neuroinflammation, which could result in
decreased neurogenesis below baseline levels in the chronic-TBI stage. One study shows
that increasing the stimulation of neurogenesis through environmental enrichment and
exercise rescues the neurogenic suppression via lipopolysaccharide-induced
inflammatory conditions (Wu et al., 2007). This suppression of neurogenic activity via
inflammatory responses would also explain many of the long-term pathological
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conditions of chronic-TBI that are reported after injury such as neurodegenerative
diseases, psychiatric disorders, and sleep disorders. These findings indicate that TBIinduced inflammatory responses may be active at 3 months post-injury, affecting the
normal neurogenic activity.

TBI-induced Inflammation Affects Long-term Neurogenesis
Concurrent with stimulated neurogenic activity that induces benefits following
TBI, studies show that other TBI induced mechanisms are also activated that are
detrimental to recovery and normal function such as progressive cell death and
inflammation in the brain (Bramlett and Dietrich, 2015). Especially in the hippocampus,
these mechanisms can be responsible for some of the cognitive deficits, sensory and
motor dysfunction, and neuropathology such as seizures seen in TBI patients (Fujimoto et
al., 2004; Gupta and Gupta, 2005). Studies have found significant cell death in the DG
after acute-TBI, especially of immature neurons (Gao et al., 2008). Inflammatory
responses after injury have been demonstrated to play a role in the regulation of
hippocampal cell death and reduced neurogenic activity through activation of microglia
that release inflammatory mediators such as IL-1, IL-6, TNF-α, reaction oxygen species
etc. (Monje et al., 2003; Ekdahl et al., 2003). These pro-inflammatory mediators are
detrimental for survival of newly generated neurons (Ekdahl et al., 2003). For example,
studies have shown that the number of activated microglia and the levels of proinflammatory cytokines, particularly IL-6 and TNF-α, produced by microglia are
correlated with decreased survival of new hippocampal neurons, and inhibition of
microglia activation with anti-inflammatory drug treatment increase the number of newly
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formed neurons (Monje et al., 2003; Ekdahl et al., 2003). It is likely that the persistent
inflammation following TBI, especially after the TBI-induced acute neurogenic stimulus
is returned to baseline, curtail the neuronal differentiation or survival of newly generated
cells. Future study using combination of BrdU with cell type specific markers is needed
to answer this question. In this study we found inflammatory responses during subacuteTBI, and this inflammation is persistent at 3 months after injury. In a previous study,
TBI-induced inflammatory responses have been detected in the striatum, thalamus, and
cerebral peduncle at 2 months after injury in conjunction with reduced levels of immature
neurons in the SGZ (Acosta et al., 2013). Our study adds to these findings showing that
inflammatory responses are extended to 3 months post injury and also detected in the DG
and cortex regions, concomitant with reduction of immature neurons in the DG.

Hippocampal morphological changes following TBI
Apart from cellular and biochemical changes, chronic assessment of TBI also
involves morphological changes. Temporal studies of histopathological changes after TBI
in rats demonstrate progressive cell death mechanisms in the cerebral cortex and
hippocampus over one year after injury (Smith et al., 1997). These cell death mechanisms
have also been linked to neurodegenerative changes. Clinical studies show changes in
white matter tracts and progressive atrophic changes in TBI patients at one year after
injury (Williams et al., 2001; MacKenzie et al., 2002). The hippocampus is particularly
vulnerable to TBI as evident from morphological changes seen in the temporal lobe,
specifically hippocampal atrophy (Ariza et al., 2006). In the present study we found TBIinduced morphological changes of the hippocampus; particularly in the LFPI model at 3
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months post-injury we found shrinkage of the hippocampus. This is consistent with
previous findings showing reduced hippocampal volume at 2 months following LFPI in
rats (Bramlett et al., 1997). Studies suggest that these morphological changes may
contribute to cognitive and behavioral changes seen in many TBI patients (Jorge et al.,
2007). Atrophy of the hippocampus may also be a contributing factor to the chronic
changes of adult neurogenesis that we found in this study.

Conclusion and Future Direction
TBI induces both acute and chronic neurological consequences that can lead to
pathological conditions such as cognitive deficits, neurodegenerative diseases, psychiatric
disorders, and seizures among many other problems (Koponen et al., 2002; Castriotta et
al., 2007; Uryu et al., 2007). The complex interplay of mechanisms that regulate these
acute and chronic conditions is not completely understood. The present study in
combination with previous studies shows involvement of a neurogenic response to TBI,
in an endogenous effort to initiate brain repair mechanisms (Sun, 2016; Sun et al., 2005).
This endogenous neurogenic response is stronger than the normal baseline adult
neurogenic activity, however, it is not continuous (Sun et al., 2005). Once this TBIinduced neurogenic response returns to baseline levels, other persistent TBI induced
mechanisms may affect normal adult neurogenic activity. In the present study we show
the involvement of inflammatory mechanisms that may regulate normal neurogenic
activity in chronic-TBI. Our study shows persistent inflammation concurrent with
reduced generation of immature neurons in chronic TBI stage.
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Further investigation is required to understand the true nature of this interaction
between chronic inflammation and reduced neurogenic activity. It is also necessary to
elucidate the phenotype of microglial activation in chronic-TBI. Studies have shown that
specific microglial phenotypes have specialized functions, such as the M1 phenotype that
has pro-inflammatory properties and the M2 phenotype that has anti-inflammatory
properties (Hsieh et al., 2013). Distinguishing the phenotype of microglia activation will
determine the nature of the inflammatory response in chronic stage of TBI.
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